University of Tennessee at Chattanooga

UTC Scholar
Honors Theses

Student Research, Creative Works, and
Publications

5-2021

Examining the effects of exogenous polyunsaturated fatty acids
on the antimicrobial activity of piscidins in Vibrio cholerae
Elizabeth Allen
University of Tennessee at Chattanooga, dwm972@mocs.utc.edu

Follow this and additional works at: https://scholar.utc.edu/honors-theses

Recommended Citation
Allen, Elizabeth, "Examining the effects of exogenous polyunsaturated fatty acids on the antimicrobial
activity of piscidins in Vibrio cholerae" (2021). Honors Theses.

This Theses is brought to you for free and open access by the Student Research, Creative Works, and Publications
at UTC Scholar. It has been accepted for inclusion in Honors Theses by an authorized administrator of UTC Scholar.
For more information, please contact scholar@utc.edu.

Examining the Effects of Exogenous Polyunsaturated Fatty Acids on the Antimicrobial
Activity of Piscidins in Vibrio cholerae

Elizabeth Allen

Departmental Honors Thesis
The University of Tennessee at Chattanooga
Department of Biology, Geology, and Environmental Science

Date:

David K. Giles, PhD

Elise Chapman, PhD

Associate Professor of Biology

Lecturer in BGE

Thesis Director

Department Examiner

Fernando Alda-Pons, PhD
Assistant Professor of Biology
Department Examiner

Table of Contents
Title Page ………………………………………………………………………………………....1
Table of Contents ………………………………………………………………………………...2
Abstract …………………………………………………………………………………………..4
Introduction ……………………………………………………………………………………...5
Antimicrobial Peptides ………………………………………………………………….5
Piscidins ………………………………………………………………………………….8
Piscidins 1 and 3 …………………………………………………………………………8
Metalation ………………………………………………………………………………..9
Polyunsaturated Fatty Acids 18:2, 20:4, 22:6 …………………………………………10
Exogenous Fatty Acid Utilization by Bacteria …………………………………….….12
Materials and Methods ………………………………………………………………………...14
Bacterial Strain and Growth Conditions ……………………………………………..14
Media Preparation ……………………………………………………………………..14
Permeability Assays ……………………………………………………………………14
Minimum Inhibitory Concentration Assays ………………………………………….15
Results…………………………………………………………………………………………...16
Permeability…………………………………………………………………………….16
Figure 1………………………………………………………………………….17

Permeability with Linoleic Acid………………………………………………………18
Figure 2…………………………………………………………………………19
Figure 3…………………………………………………………………………20
Figure 4…………………………………………………………………………21
Figure 5…………………………………………………………………………22
Determinization of Minimum Inhibitory Concentration of Piscidins………………22
Figure 6…………………………………………………………………………23
Figure 7…………………………………………………………………………24
Figure 8…………………………………………………………………………25
Figure 9………………………………………………………………………….26
Table 1…………………………………………………………………………...27
Discussion……………………………………………………………………………………….27
Future Directions……………………………………………………………………………….34
Bibliography ……………………………………………………………………………………36

4
Abstract
Antimicrobial peptides are found in all organisms and have gained notoriety in recent years
for their effectiveness against a variety of pathogens. Piscidins, first isolated from the mast cells
of vertebrates, comprise a family of these host defense peptides. Piscidins 1 (P1) and 3 (P3), found
in sea bass and other fishes, are isoforms with different modes of action. P1 induces membrane
perturbation, while P3 binds DNA to exert antibacterial activity. Each has the ability to bind Cu2+
(P1Cu and P3Cu) which dramatically impacts their antimicrobial characteristics. The purpose of
this study was to investigate the activity of metallated and nonmetallated P1 and P3 on Vibrio
cholerae, a Gram-negative bacterium of medical importance that normally inhabits an aquatic
environment, often associating with fish and other marine life. Known to assimilate exogenous
fatty acids into membrane phospholipids, V. cholerae possesses the ability to modify membrane
permeability depending upon environmental fatty acid availability. Herein we investigated both
permeability and antimicrobial effects of P1, P1Cu, P3, and P3Cu on V. cholerae grown in the
presence and absence of linoleic acid (18:2), arachidonic acid (20:4), and docosahexaenoic acid
(22:6). Membrane permeability was assessed using a crystal violet assay. These experiments
observed a marked decrease (~15%) in permeability when the bacteria is provided each of the fatty
acids. All piscidins elicited heightened permeability, with 18:2 decreasing the effect for
nonmetallated forms of the peptide. Furthermore, some piscidins displayed concentration
dependence with regard to permeability effects. The minimum inhibitory concentrations (MICs)
for P1 were increased 2-fold when any of the fatty acids were available. The MIC of P1Cu
increased 2-fold with 20:4 and 4-fold with 22:6. The MIC of P3 decreased 2-fold with 20:4 and 4fold with 18:2. The MIC of P3Cu increased 2-fold with 20:4. Not only do piscidins alter bacterial
membrane permeability and display promising antimicrobial capabilities, but the observed effects
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of exogenous fatty acid supplementation could also hold potential for targeted treatment of
infectious disease.

Introduction
Antimicrobial Peptides
Antimicrobial peptides are a vital component of the innate immunity in all organisms and
have been regarded as the first line of defense against bacterial invaders [14,18]. These peptides
are unique in that their small size, cationic charge, amphipathicity, hydrophobicity, and membrane
self-association allows for diffusion or secretion into or out of cells and targeting cell types through
membrane interactions [27]. The emergence of antibiotic resistance following the Golden Age of
Antibiotics led to the newfound interest in antimicrobial peptide research as they are produced
within the organism that they protect, and they have numerous modes of action that could
potentially prevent the evolution of resistance in pathogens [40,37]. Later research expanded upon
the effectiveness of antimicrobial peptides, demonstrating the ability of the peptides to also have
activity on fungi, yeasts, viruses, and potentially cancerous cells [40]. The attack of an
antimicrobial peptide can be pathogen specific, or it can be broad-spectrum depending on the
peptide in question [3]. The activity of these peptides is not limited to attack of pathogens, as they
have also been recognized as modulating the inflammatory response and cancer cell behavior
[3,23]. Additionally, these peptides have been shown to have properties that allow them to act as
signaling molecules, mitogenic agents, contraceptives, antitumor agents, and drug deliverers [27].
The versatility of antimicrobial peptides warrants a need for further research on how supplemented
usage might improve the quality of life in organisms that rely so heavily on them, especially for
unlocking cross-species therapeutic potential.
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Antimicrobial peptides are found in all organisms, ranging from single celled organisms to
complex organisms with comparably complex organ systems [8]. In fact, over 16,800
antimicrobial peptides have been characterized as of 2021 [7]. These peptides are synthesized by
the organism in which they protect, and often are best at attacking biologically relevant microbes
[40,37]. One study aimed to characterize the diversity of antimicrobial peptides found that cattle
have at least 13 major antimicrobial peptides, sheep have at least 11, goats have at least 4, pigs
have at least 9, and poultry have at least 8 [3]. In these agricultural organisms, the peptides are
found as a vital component of the majority of the major organ systems: integumentary, skeletal,
muscular, nervous, endocrine, cardiovascular, lymphatic, respiratory, digestive, and urinary [3].
The reliance on antimicrobial peptides is not limited to domesticated animals as one study
identified the sources of antimicrobial peptides in various other organisms including but not
limited to insects, amphibians, echinoderms, crustaceans, plants, bacteria, fungi, and fishes [27].
Much like the domesticated animals, all of these organisms have a wide variety of antimicrobial
peptides found at different locations within the body or the cell [27]. In humans, much like in
animals, antimicrobial peptides have the potential to serve an abundance of purposes. It is evident
that these peptides have the ability to target pathogens, and recent research has shown the potential
for the targeted treatment of cancer cells through matching membrane composition with peptide
affinity [23]. One example comes from a study that found antimicrobial peptides composed of Dand L-amino acids were extremely effective at killing cancer cells through a necrotic pathway [23]
These peptides have proven to be a vital component of life in many organisms, serving numerous
roles that aid in the maintenance of homeostasis.
These cationic peptides attack pathogens through either direct attack by intracellular
targeting or cell lysis, or they stimulate the immune system of the host for indirect killing of the
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pathogen [14,40]. Direct attack of pathogens by antimicrobial peptides can be performed through
membrane disruption or through causing chaos within the cell to such an extent that cell lysis
occurs [40]. The ability of antimicrobial peptides to disrupt bacterial cell membranes is reliant on
the electrostatic interactions between the hydrophobic amino acids that comprise the peptide and
the negatively charged phospholipids that make up the lipid membrane of bacterial cells [40,14].
Through these interactions, the peptides have the ability to completely alter the membrane from
outside of the cell through aggregation and pore formation [40] Another mechanism for membrane
disruption by antimicrobial peptides relies largely on weak spots in the bacterial membrane that
would allow minimal enzymatic activity to degrade the phospholipids that are protecting the cells
from their environment [40,14].
The mechanism of intracellular targeting is dependent on the antimicrobial peptide and the
bacteria that is being attacked. Generally, it is accepted that some antimicrobial peptides have the
ability to translocate across the bacterial cell membrane, causing no damage as they pass, for
inhibition of vital intracellular activities that eventually lead to cell death [14,40]. The immune
response due to antimicrobial activity is believed to occur through the peptides modulating
immunocytes, up- or down-regulating essential communication components of the innate and
adaptive immune response and speeding the maturation of specific kill cells [40,8]. These defense
peptides are not limited to membrane and DNA/RNA attack [28]. In fact, they have been noted to
interact with nucleotides, for example ATP, ribosomes, signaling pathways, and free lipids [28].
In summary, the known functions of antimicrobial peptides point to positive activity through
mechanisms that allow the peptides to have antifungal, antiviral, antiparasitic, antibiofilm,
antibacterial,

anti-inflammatory,

pro-inflammatory,

chemotaxis,

adjuvant,

anti-cancer,

cytotoxicity, angiogenesis, wound healing, homeostasis, and aggregation activity. [28].
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Piscidins
The first antimicrobial peptides that were isolated from the mast cells of vertebrates were
closely related to the piscidins examined in this study [14]. Piscidins were first isolated from the
mast cells of seabass and are in the same family as the first antimicrobial peptides isolated from
the mast cells of vertebrates [14,18]. Piscidin 1 and piscidin 3 have been researched thoroughly
since the discovery that the two antimicrobial peptides possess anticancer, anti-HIV1, and broadspectrum antimicrobial properties on both Gram-positive and Gram-negative bacteria [14,18].
Previous research has shown that piscidins are generally more active on Gram-positive bacteria
than Gram-negative bacteria [14]. Piscidins are opportunistic antimicrobial peptides given that
their membrane attack begins in areas of the membrane that contain transient defects [24]. The
general structure of piscidins is a 22-residue-long peptide with high concentrations of the amino
acids arginine, lysine, tryptophan, and histidine [14]. Unlike many other antimicrobial peptides,
piscidins have an extremely large histidine concentration [14]. Additionally, piscidins are
amphipathic [14]. Piscidins are found throughout numerous taxa, including but not limited to
Anoplopomatidae, Cyprinodontidae, Fundulidae, Adrianichthyidae, Sebastidae, Gasterosteidae,
Sparidae, Sygnathidae, Cichlidae, Latridae, Belonidae, Percichthyidae, Sciaenidae, Siganidae, and
Moronidae [30]. While piscidins have specifically been isolated from numerous fish species, many
other organisms possess piscidin-like peptides [14].

Piscidin 1 and Piscidin 3
Piscidin

1

(p1,

FFHHIFRGIVHVGKTIHRLVTG‐NH2)

and

piscidin

3

(p3,

FIHHIFRGIVHAGRSIGRFLTG‐NH2) have been researched thoroughly since the discovery of
the two antimicrobial peptides [14,18]. These peptides are homologues of one another, yet they

9
behave very differently [14]. Previous research has shown that piscidin 1 and 3 are both more
active on Gram-positive bacteria than Gram-negative bacteria [14]. Piscidin 1 exhibits stronger
antimicrobial hemolytic activity out of the two peptides [14]. Piscidin 3 tends to have a more
condensing effect on DNA, which is a contrast to piscidin 1 in that it has shown more membrane
activity [14,22]. It is believed that the unusually high histidine concentration in both piscidins gives
the two peptides the unique ability to translocate across the bacterial cell membrane [14]. The basic
structures of both P1 and P3 indicate that their N and C terminus ends have different
amphipathicities, which the peptides make up for with a unique structure that is much like a
disrupted α-helix [25,4]. Additionally, both peptides are bent around a central glycine that helps
to increase their surface area and improve their interactions with the hydrophobic sections of the
bacterial membrane lipid bilayer [4]. By doing so, both piscidins are able to change form to best
interact with bacterial cell membranes by controlling electrostatic interactions between themselves
and the membrane phospholipids [25]. Once in the lipid bilayer, in the case of translocation, each
piscidin forms a wedge with their sidechains distributed so that the evidence of membrane
penetration is small if any is left at all [5]. Perhaps this is the reason for their efficiency in disabling
bacterial invaders and providing a line of defense for the organisms in which these piscidins are
found.

Metalation
Both piscidin 1 and piscidin 3 contain an ATCUN (amino terminal copper and nickle)
binding motif that is utilized in the binding of Cu2+ [18]. It is believed that piscidins are
unmetallated in the mast cells of seabass, but that they gain the Cu2+ through immune response
pathways as the cell responds to invaders [17]. The piscidin-Cu2+ interaction is dependent on
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oxygen, and, thus, cannot be accurately tested in anaerobic conditions [22]. In these aerobic
conditions, both P1 and P3 utilize picomolar affinity to bind the ATCUN motif with copper [22].
Research performed by cleaving the Cu2+ tail off of piscidin 1 and piscidin 3 showed that the Cu2+
tail of piscidin 1 did not have a significant impact on the antimicrobial properties of piscidin 1, but
the loss of the tail decreased the antimicrobial properties of piscidin 3 [17]. In fact, P3 relies heavily
on copper to form the ROS needed to nick DNA, so P3Cu complete cell death at a lower
concentration than P3 [17]. In aerobic environments, it has been found that piscidins with a copper
interaction elicit a greater bacterial death response than does piscidins alone or copper alone [22].
In contrast to copper having an additive role in piscidin activity, another study concluded that the
Cu-ATCUN motif itself inhibits the microbe that it comes in contact with, taking a lot of the
responsibility away from the piscidins [1]. The latter conclusion is challenged by another study
that demonstrated the impact that piscidins had on C. difficile was neither inhibited nor enhanced
with the presence of the Cu2+ tail [22].

Polyunsaturated Fatty Acids 18:2, 20:4, and 22:6
Polyunsaturated fatty acids (PUFAs) are essential to the lipid membrane of every cell
species due to their roles in maintaining healthy communication with other cells and due to their
assistance in maintaining the fluidity of the membrane [33]. These long chain molecules can vary
significantly in length, degrees of unsaturation, and location of cis bonds. PUFAs are classified as
either omega 3 or omega 6 fatty acids, characterized by the placement of the last double bond on
the terminal methyl end [35]. Both omega 3 and omega 6 fatty acids have also been identified as
immune system modulators in the organisms that they reside in [33]. This is performed by way of

11
a variety of mechanisms, but most notably through membrane uptake in all cells, eicosanoid
metabolism, altering their gene expression, and altering their cellular signaling [33, 26].
Omega 3 and omega 6 fatty acids are tricky to have a healthy balance of as they are not
synthesized in humans and must be obtained through a balanced diet [6]. Omega 3 fatty acids have
been specifically recognized as reducing the incidence of myocardial infarction, hyperlipidemia,
hypertension, rheumatoid arthritis [6.]. On the contrary, excess omega 6 fatty acid levels have been
shown to result in increased rates of cardiovascular disease, cancer, inflammation, and
autoimmune diseases [19]. A higher ratio of omega 6 to omega 3 fatty acids has shown to increase
muscle mass in patients undergoing hemodialysis who would normally be regarded as having a
lower muscle mass due to the treatments [39]. On the other hand, lower ratios of omega 6 to omega
3 fatty acids during childhood was found to result in stunted growth and short stature [32]. It is
evident that these PUFAs play a major role in human health and development, and that a healthy
ratio of omega 3 to omega 6 fatty acids promotes better health outcomes.
Linoleic acid (18:2) is an omega 6 fatty acid from which many of the long chain fatty acids
are derived [26]. Arachidonic acid (20:4) is an omega 6 fatty acid metabolized from 18:2 and falls
into the group ‘eicosanoid’ due to having 20 carbons [33]. The mechanism by which these types
of fatty acids can impact the immune response in the organisms that have them is through
exhibiting anti-inflammatory properties that can be easily up or downregulated through
competitive inhibition [33]. Most notably for this project, 20:4 has a phenomenal impact on cell
membranes [34]. As with the other fatty acids being tested, 20:4 plays an important role in
maintaining membrane fluidity [34]. Additionally, 20:4 has a direct impact on the function of many
membrane proteins and, thus, plays a role in maintaining the stability of the cell both externally
and internally [34]. As well as maintenance of homeostasis, 20:4 also has roles in cell death. Free
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20:4 has previously been proved to be cytotoxic to cells and must be actively kept in check by the
cells [34]. The fatty acid docosahexaenoic acid (22:6), on the other hand is an omega 3 fatty acid
[26]. When an organism has an omega 6 fatty acid balance that is no longer optimal,
supplementation of 22:6 has the ability to correct this issue and prevent inflammatory diseases that
may arise due to the cytotoxicity of fatty acids such as 20:4 and 18:2 [35]. The biological relevance
of each fatty acid for humans differs slightly. 18:2 is abundant in cell membranes of intestinal
mucus secreting cells and has anti-inflammatory and surfactant properties [11]. 20:4 is extremely
common in most eukaryotic cell phospholipids and plays a role both as a signaling molecule and
an inflammatory intermediate [11]. 22:6 is the omega 3 fatty acid with the highest concentration
in the brain and retina, allowing for significant impact on early fetus development, mental health,
cardiovascular disease, and anticancer properties [11,26]. All of these three fatty acids prove to be
essential in the maintenance of homeostasis in nearly all organisms.
Analysis of various freshwater fish species revealed that 18:2 and 22:6 are of the highest
concentration of fatty acids among freshwater fishes [31]. Other studies highlight the significance
of 22:6 in marine fishes, while also noting that eicosapentaenoic acid (20:5), a derivative of 20:4,
are the two most abundant fatty acids in salt-water environments [35]. Since the piscidins utilized
in this study are isolated from a fish species, each of these fatty acids prove to be biologically and
physiologically relevant, mimicking what would be found in the natural environment.

Exogenous Fatty Acid Utilization of Bacteria
The first observation that suggested the possibility of exogenous PUFA uptake was seen in
Vibrio fischeri, setting the stage for continued exploration into this phenomenon [38]. Later studies
with Vibrio cholerae, the first bacteria to be examined for this activity, further analyzed the affinity
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for the uptake of exogenous PUFAs into a bacterial cell membrane [10]. In these studies, V.
cholerae was grown in the presence of exogenous PUFAs and assessed using thin-layer
chromatography and ultra-performance liquid chromatography-electrospray ionization mass
spectrometry, both of which indicated that the V. cholerae exhibited unique membrane remodeling
consistent with assimilation of the available fatty acids into phospholipids [10]. In further studies,
the impact that fatty acid assimilation had on V. cholerae treated with polymyxin B was assessed
through minimum inhibitory concentration assays [20]. In these assays, 18:2, 20:4, and 22:6 all
resulted in the bacteria having increased susceptibility to polymyxin B as the subinhibitory
concentration had a 2-fold decrease in the V. cholerae that was grown with exogenous PUFAs
[20]. In these studies, V. cholerae was also examined for phenotypic behavior associated with
virulence, including motility and biofilm formation. PUFAs were found to affect these phenotypes
to varying degrees [10].
In recent years, several other Gram-negative bacteria have exhibited the ability to
assimilate exogenous PUFAs for membrane remodeling as well as altering swimming motility and
biofilm production [2,9,15,16]. Studies surrounding Escherichia coli’s ability to handle PUFAs
showed that most of the PUFAs were actually incorporated into the bacteria’s membrane, eliciting
a higher overall bacterial growth [15]. Likewise, Acinetobacter baumannii was shown to
incorporate PUFAs into its bacterial membrane, causing various behavioral changes throughout
all tested phenotypes [9]. Pseudomonas aeruginosa was determined to incorporate the exogenous
PUFAs into phosphatidylethanolamine and phosphatidylglycerol, resulting in an increased
resistance to polymyxin B, a cyclic antibiotic peptide [2]. Similarly, Klebsiella pneumoniae was
shown to modify its membrane with exogenous PUFAs, resulting in decreased susceptibility to
polymyxin B and colistin [16]. All of these studies have proven that Gram-negative bacteria have
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much more fatty acid handling capabilities than we had previously thought. For this study, we
hypothesized that the uptake of fatty acids would improve bacterial resistance to piscidins. The
mechanism that we projected this occurring was through the bacteria utilizing the fatty acids to
strengthen weak spots in the bacterial membrane that would normally be a target for the piscidins.

Methods
Bacterial Strain and Growth Conditions
The bacterial strain used in all assays was Vibrio cholerae El Tor C6706. The V. cholerae
overnight cultures were grown in Luria-Bertani (LB) broth for all assays. The media utilized in
experimentation was M9 minimal media buffered with HEPES (pH 7.4) and supplemented with
casamino acids (2%) and glucose (2%). The fatty acids (linoleic acid [18:2], arachidonic acid
[20:4], and docosahexaenoic acid [22:6]) that were supplemented at a concentration of 300 μM to
the V. cholerae throughout all trials were produced by Cayman Chemicals.

Media Preparation
For all assays on piscidin, we utilized CM9/HEPES (pH 7.4) media consisting of the
following: 100mM HEPES (pH 7.4), M9 Salts, 0.4% glucose, 0.4% casamino acids, 2 μM MgSO4,
and 0.1 μM CaCl2.

Permeability Assays
The permeability of V. cholerae’s membrane was assessed using crystal violet permeability
assays. This assay measured the uptake of the hydrophobic compound crystal violet by utilizing
its peak spectrophotometric detection at an absorption of 590nm. V. cholerae from an overnight
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culture was grown in 3 mL of a CM9/HEPES (pH 7.4) in the presence and absence of each PUFAs,
18:2, 20:4, and 22:6 (starting OD600= 0.2). The bacteria were allowed to grow in the presence or
absence of PUFA for 45 minutes to midlogarithmic growth phase. After this time, a subinhibitory
concentration of the appropriate piscidin, P1, P1Cu, P3, or P3Cu, was added to the respective tube.
All samples were then incubated shaking for an additional 45 minutes. These cultures were pelleted
using centrifugation, washed with phosphate buffered saline, and resuspended in 1 mL of
phosphate buffered saline. The OD600 of each sample in a 10-1 dilution was captured using a
spectrophotometer. Using the lowest of these OD600, we calculated the volumes of the bacterial
sample that would be added to phosphate buffered saline to achieve 2 mLs at a starting OD600 of
0.7. Once the tubes (OD600= 0.7) were prepared, we added 2 μL of crystal violet to each sample.
Then, every 7 minutes for 21 minutes, 650 μL of culture was pelleted (1 minute, 13,000g) and the
supernatant was placed in a cuvette for analysis of absorbance at 590nm for determination of
crystal violet not taken up by the bacteria. Data was normalized against a control containing the
equivalent amount of crystal violet but no bacteria. Statistical analysis was performed to compare
treatments (3 readings for each) by using the Student’s T-test (Paired, two-tail). Three biological
replicates were performed for the uptake assays.

Minimum Inhibitory Concentration Assays
The OD600 of an overnight culture was captured using a spectrophotometer to calculate the
volume of the V. cholera to add to 5 mL of a CM9/HEPES (pH of 7.4) for a starting OD600 of 0.2.
Then, bacteria were grown in this media either in the presence or absence of PUFAs for one and a
half hours to logarithmic phase. After this time, we prepared 1 mL of a 0.016 dilution using the
OD600 of each sample. This 0.0016 dilution was used to make a 10-1 dilution of bacteria with media
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that either contained a PUFA or did not. As previously destermined in our laboratory, this dilution
scheme results in an inoculum that yields 5 x 105 cfu mL-1 when applied to our MIC broth
microdilution assays. 30 μL of two-fold concentrations of each piscidin was plated into two rows
on a microtiter plate: piscidin without fatty acid and piscidin with fatty acid [41]. 170 μL of the
appropriate bacterial inoculum was added to the respective well containing the 30 μL of piscidin
for a total volume of 200 μL. 200 μL of sterile water was added to the surrounding wells to help
avoid evaporation of the sample wells during incubation. The finished plate was incubated for 24
hours at 200 rpm at 37oC. The absorbance of this plate was then read using at OD600 using a Biotek
Synergy microplate reader. The Student’s T-test was used to determine significance compared to
control at a given piscidin concentration. Figures are a representative from three independent
experiments conducted in triplicate, with each value representing the mean.

Results
Permeability
In order to verify that the V. cholerae was taking up the exogenous fatty acids and to
establish a baseline for fatty acid impacts on membrane permeability without the interference of
piscidins, the membrane permeability of V. cholerae was assessed using crystal violet. Fatty acid
availability during growing periods of V. cholerae significantly decreases membrane permeability.
While the permeability assays of each of the fatty acids represented in Figure 1 significantly
decrease membrane permeability, 20:5 has the highest percent difference from the control. No
further experiments were performed with 20:5. 20:4 and 22:6 had very similar impacts on
membrane permeability, and 18:2 had the least benefit to V. cholerae in terms of strengthening the
membrane. In most cases, time was not a limiting factor for the membrane permeability as the
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percent crystal violet uptake did not change very much at each time period measured. Further
permeability assays were performed with 18:2 and piscidins P1, P1Cu, P3, and P3Cu. Collectively,
PUFAs decreased the permeability by 15-20% compared to the control, a significant difference.

Figure 1: Assessment of Vibrio cholerae’s membrane permeability when V. cholerae is
grown in the presence of PUFAS as compared to growth without exogenous fatty acids.
Percent crystal violet uptake is indicative of membrane strength as a stronger membrane will
limit the amount of crystal violet detected by a spectrophotometer. The asterisks indicate a
significant difference (*, P<0.01) compared to the control.
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Permeability with Linoleic Acid
Our next goal was to assess the piscidin-mediated permeability impact on linoleic acid fed
cultures of V. cholerae had on the membrane activity of each piscidin. Each experiment included
two-fold concentration increases of piscidin in order to assess the role that antimicrobial peptide
concentration might have on the bacteria’s ability to withstand membrane disruption. Figure 2
shows that the presence of exogenous linoleic acid during the growing period of V. cholerae
significantly decreased membrane permeability at all concentrations of P1. In fact, higher
concentrations of P1 in the samples grown with 18:2 performed comparable to the fatty acid
control that was grown with 18:2 had not been exposed to P1. The no fatty acid and no P1 control
showed membrane strength similar to that of the samples that were grown with 18:2 and had been
exposed to lower concentrations of P1. All samples containing 18:2 were significantly
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Figure 2: Assessment of Vibrio cholerae’s membrane permeability with linoleic acid
incorporation and 2-fold concentrations of piscidin 1. The asterisks indicate a significant
difference (*, P<0.01) compared to the control.

Permeability of V. cholerae’s membrane was less reliant on the presence or absence of 18:2
when being acted upon by P1Cu. The results from the permeability assays with P1Cu are shown
in Figure 3. The presence of 18:2 increased membrane permeability at all concentrations of P1Cu.
Overall, P1Cu was much more effective than P1 at increasing membrane permeability at all
concentrations regardless of exogenous 18:2 availability. The 8μM sample with 18:2 and the no
P1Cu/18:2 sample were significantly different than the control.
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Figure 3: Assessment of Vibrio cholerae’s membrane permeability with linoleic acid
incorporation and 2-fold concentrations of piscidin 1-Cu2+. The asterisks indicate a significant
difference (*, P<0.01) compared to the control.

Membrane permeability of V. cholerae treated with P3 yielded results similar to but less
pronounced than that of P1. Figure 4 shows that the presence of 18:2 decreased the permeability
of V. cholerae’s membrane just slightly at all concentrations of P3 excluding 2μM. As with P1Cu,
the impact that the presence or absence of 18:2 had on the effectiveness of P3 was much less drastic
than what was seen with P1. All samples containing 18:2 excluding 8μM were significantly
different than the control.
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Figure 4: Assessment of Vibrio cholerae’s membrane permeability with linoleic acid
incorporation and 2-fold concentrations of piscidin 3. The asterisks indicate a significant
difference (*, P<0.01) compared to the control.

The permeability of V. cholerae’s membrane was generally increased in the presence of
18:2 when treated with P3Cu. Figure 5 shows that 18:2 raised the percent crystal violet uptake at
all concentrations of P3Cu excluding 8μM after 14 minutes. This impact is the most significant at
2μM of P3Cu than at any other concentration. As with the previous results, the impact that the
presence or absence of 18:2 had on the membrane permeability of V. cholerae was much less
pronounced. The 2μM and 4μM samples containing 18:2 as well as the no P3Cu/18:2 were
significantly different than the control.
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Figure 5: Assessment of Vibrio cholerae’s membrane permeability with linoleic acid
incorporation and 2-fold concentrations of piscidin 3-Cu2+. The asterisks indicate a significant
difference (*, P<0.01) compared to the control.

Determination of Minimum Inhibitory Concentration (MIC) of Piscidins
Our next goal was to determine the impact that exogenous fatty acid uptake of Vibrio
cholerae had on the MIC of the various piscidin forms. Figure 6 outlines the results from the MIC
assays of P1 when acting on V. cholerae that was grown in the presence or absence of 18:2, 22:6,
or 20:4. Uptake of 20:4 provided V. cholerae no change in resistance to the antimicrobial properties
of P1 as both the 20:4 sample and control died at 16μM of P1. The uptake of 22:6 resulted in a
two-fold increase of the concentration of P1 required to kill V. cholerae (MIC=32μM). 18:2 had
no impact on MIC.
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Figure 6: Determination of the minimum inhibitory concentration of Vibrio cholerae grown
in the presence of 18:2, 20:4, or 22:6 when treated with 2-fold concentration increases of
piscidin 1. The symbols circled by a dotted line indicate significant differences (P<0.02)
compared to the control (no fatty acid) at the particular piscidin concentration.

In contrast to the MIC assays with P1, the assays with P1Cu show that 18:2 did not provide
V. cholerae any protection from the antimicrobial abilities of the piscidin. Figure 7 illustrates the
MIC for both the 18:2 sample and the control are 16μM of P1Cu. On the other hand, the MIC
increased two-fold for 20:4, and it increased four-fold for 22:6. The uptake of exogenous 22:6 had
an extreme impact on the MIC with P1Cu.
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Figure 7: Determination of the minimum inhibitory concentration of Vibrio cholerae grown
in the presence of 18:2, 20:4, or 22:6 when treated with 2-fold concentration increases of
piscidin 1-Cu2+. The symbols circled by a dotted line indicate significant differences (P<0.02)
compared to the control (no fatty acid) at the particular piscidin concentration.

Unlike the previous assays, the results of the MIC with P3 show that the uptake of
exogenous fatty acids might have a negative impact on the survival of V. cholerae. Figure 8 shows
that, in all cases, fatty acid availability either decreased or had no impact on the survival of V.
cholerae treated with P3. Both the control and the 22:6 sample had an MIC of 64μM of P3. The
20:4 sample experienced a two-fold MIC decrease (MIC=32μM). The 18:2 sample showed a fourfold MIC decrease with growth inhibition occurring at 16μM.

25

Figure 8: Determination of the minimum inhibitory concentration of Vibrio cholerae grown
in the presence of 18:2, 20:4, or 22:6 when treated with 2-fold concentration increases of
piscidin 3. The symbols circled by a dotted line indicate significant differences (P<0.02)
compared to the control (no fatty acid) at the particular piscidin concentration.

MIC assays for P3Cu, shown in Figure 9, identified only 20:4 as changing the
antimicrobial activity resistance to P3Cu, increasing the MIC two-fold. The control, the sample
grown with 18:2, and the sample grown with 22:6 all were inhibited at 32μM of P3Cu.
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Figure 9: Determination of the minimum inhibitory concentration of Vibrio cholerae grown
in the presence of 18:2, 20:4, or 22:6 when treated with 2-fold concentration increases of
piscidin 3-Cu2+. The symbols circled by a dotted line indicate significant differences (P<0.02)
compared to the control (no fatty acid) at the particular piscidin concentration.

Summaries of the minimum inhibitory concentration assay results are shown in Table 1
with emphasis placed on more dramatic increases or decreases in MIC. It is evident that each
piscidin behaves differently from the next, and that membrane composition has at least some
impact on the antimicrobial properties of each piscidin.
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TABLE OF MIC VALUES
No FA

18:02

20:04

22:06

P1

16

16

32

32

P1Cu

16

16

32

64

P3

64

16

32

64

P3Cu

32

32

64

32

Table 1: Summary of MIC results for assays with P1, P1Cu, P3, and P3Cu grown with and
without exogenous polyunsaturated fatty acids. 2-fold concentration increases of MIC are
represented by a light red fill. 2-fold concentration decreases of MIC are represented by a
light blue fill. 4-fold concentration increases of MIC are represented by a dark red fill. 4fold concentration decreases are represented by a dark blue fill.

Discussion
Research on antimicrobial peptides provides great promise for future medical
advancements and revolutionized treatment options. These options are not limited, as antimicrobial
peptides have the potential to act as a magic bullet to target pathogens while causing minimal harm
to surrounding cells. Additionally, the issue of antibiotic resistance could potentially become null
and void. The types of invaders that individual piscidins and other antimicrobial peptides could
help combat are abundant as these proteins are not limited to a single conformation, and each
conformational change has the potential to dramatically impact the activity of the peptides.
Piscidin 1 is accepted as having a membrane attack mode of action regardless of metalation
[14]. Piscidin 3 is accepted as having a DNA condensing mode of action regardless of metalation
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[14]. As immune signaling molecules, both piscidin 1 and piscidin 3 interact with G-protein
coupled receptors to act on neutrophils of Gram-negative bacteria in order to induce chemotaxis
[22]. The presence of the copper tail decreases immune response in each of these peptides [22].
Our initial permeability assay represented in Figure 1 served as a baseline for further
experimentation and showed that the uptake of exogenous fatty acids did decrease the permeability
of Vibrio cholerae’s membrane. This would support the idea that the V. cholerae might be able to
use these environmental fatty acids to strengthen its membrane through filling weak spots that
would be ideal for membrane attack of antimicrobial peptides. This finding is important to note
since previous research highlights the importance of transient defects of bacterial cell membranes
for the success of the membrane activity of both piscidins [14]. Accordingly, the membrane
activity could be due to the composition of the bacterial cell phospholipids and piscidin’s attraction
to certain fatty acids [40]. In such cases, membrane remodeling could either provide resistance or
vulnerability to piscidin. The prospect of bacterial hijacking of host fatty acids to improve survival
warrants further study.
As shown in Figure 2, the incorporation of 18:2 into V. cholerae’s membrane provided
resistance to P1 at all concentrations. The resistance in the 18:2 samples treated with 1μM and
2μM of P1 were extremely similar to that of the control that was not treated with P1 or 18:2,
indicating that at these concentrations 18:2 can preserve V. cholerae’s membrane to it’s absolute
baseline strength. The 18:2 samples treated with 4μM, 8μM, and 16μM of P1 showed membrane
strength similar to that of the V. cholerae grown with 18:2 and not treated with P1, indicating that
higher P1 concentrations did not cause additional membrane disruption. In all cases, the presence
of 18:2 significantly decreased membrane permeability, allowing for resistance to P1 almost
entirely.
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The presence of 18:2 provided consistently heightened permeability with P1Cu. This is
illustrated in Figure 3 where it can be noted that at all concentrations of P1Cu, the respective
sample treated with 18:2 had a noticeably higher membrane permeability. This indicates that the
presence of 18:2 made V. cholerae more susceptible to the antimicrobial properties of P1Cu. This
could be due to an increased binding affinity between 18:2 and P1Cu. In fact, one study identified
copper as a metal that, when bound to 18:2, induces the most prominent changes to the fatty acid’s
binding to other molecules in human serum [21]. It is possible that the copper tail on the piscidin
disrupts the connection that 18:2 has with other membrane lipids, causing compromised membrane
stability and increased permeability. In such cases, the 18:2 would act as a target for the piscidin,
thus, allowing piscidins with a copper interaction to be more effective on bacterial cells that have
a higher concentration of 18:2 in their membrane composition. Additionally, P1Cu was more
effective at disrupting the membrane of V. cholerae in all conditions and concentrations of P1Cu
than P1 was. This is not entirely surprising since previous research has shown that the copper
interaction of P1Cu might render it more effective [17].
Similarly to the permeability assays with P1, 18:2 appeared to provide some resistance to
the antimicrobial properties of P3 (shown in Figure 4). This resistance, however, was much less
substantial than what was seen in the assays with P1. Since P1 is the more membrane active out of
the two, it is reasonable to assume that P1 relies on the weak spots in the bacteria’s membrane that
have been filled with 18:2, whereas P3 is disrupting the membrane through another mechanism
[14]. One of the previously discussed mechanisms of antimicrobial peptide activity included the
possibility of translocation across the bacterial cell membrane and causing cell lysis by halting or
disrupting vital intracellular processes that, when stopped, will cause bacterial cells to undergo
necrotic cell death [13]. As previously discussed, NMR structures have shown that both P1 and P3
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are capable of penetrating cell membranes without leaving a trace due to altered side group
positions [5,29]. It has been noted that P3 has the ability to translocate across bacterial cell
membranes and act on DNA, condensing the genetic material and stopping the essential process
such as protein production [14]. In such case, necrosis is a reasonable explanation for the increased
permeability of V. cholerae’s membrane despite the uptake of 18:2 since P3 likely does not rely
on transient membrane defects as much as P1. Necrosis explains the extreme permeability increase
without direct membrane activity of P3 as the cells will eventually release their contents and the
membranes will rupture [13].
Like with P1Cu, 18:2 appeared to have less of a protective impact on V. cholerae than what
is seen with the nonmetalated forms. Again, this could be due to a change in charge on the peptide
when the copper ion is present that alters the binding affinity between the piscidin and 18:2 [21].
Since P1 and P1Cu are generally recognized as the more membrane active piscidins, this theory
would better explain the enhanced membrane disruption seen with P1Cu in the samples grown
with 18:2 than it does for P3Cu [14]. Previous studies on the binding of copper to DNA found that
copper alone has the ability to alter the conformation of DNA, which completely disrupts
translation and transcription and eventually leads to cell death [12]. While the interaction between
the copper and the 18:2 could explain a closer association and a chemical signal between the
bacterial cell and the P3Cu, it is more likely that the piscidin is still acting mostly on the DNA
given that the majority of the peptide is prone to DNA activity. The addition of the copper, however
could also render the P3Cu less effective at translocation across the bacterial cell membrane. When
comparing the results from Figure 4 and Figure 5, it is evident that P3 is slightly more active. The
increased mass, volume, and positive charge that accompany the copper interaction might make
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passage through the membrane and access to DNA more difficult. Generally, higher concentrations
of P3Cu caused higher permeability.
In the MIC assays, the concentration of piscidin required to inhibit the growth of V.
cholerae varied greatly between each piscidin. In the case of P1, assimilation of 22:6 strengthened
V. cholerae’s resistance to the peptide. Since P1 is known to rely on weak spots in the bacterial
cell membrane, this is again explained when noting that the bacteria is likely using the exogenous
fatty acids mostly for repair of membrane defects [14,10]. This is further supported by Figure 6
as it is evident that the V. cholerae samples that were not grown with exogenous fatty acids are
significantly more susceptible to the antimicrobial properties of P1. This susceptibility becomes
resistance when 22:6 is present, requiring a double in P1 concentration to inhibit the growth of V.
cholerae.
When P1 is metalated, 18:2 is the least desirable fatty acid for V. cholerae as it has no
impact on the resistance of the bacteria to the P1Cu. On the other hand, 20:4 provided resistance
that required double the concentration of P1Cu to inhibit the bacteria, while 22:6 provided a
resistance that required quadruple the concentration of P1Cu to inhibit V. cholerae. The substantial
increase in resistance seen in V. cholerae grown with 22:6 is intriguing and begs the question of
why.
The assays with P3 were unique from those with P1 and P1Cu because exogenous fatty
acid availability resulted in either no resistance or increased susceptibility to P3. It appears as
though the assimilation of certain fatty acids and incorporation into the bacterial membrane helps
P3 gain access to the cell. Since the mechanism of action of P3 is to condense DNA, it is reasonable
to assume that this access readily allows P3 entry into the cell through the cell membrane. In
contrast to the dramatic results seen with P1Cu, 22:6 had no impact on the minimum inhibitory
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concentration of P3. It could be speculated that 22:6 acts to preserve the membrane of V. cholerae,
making it more difficult for P3 to enter the cell. When 18:2 was present, P3 killed V. cholerae at a
concentration similar to that of P1 acting on V. cholerae grown without fatty acids. The fatty acid
synergism with piscidins greatly impacted the MIC of P3, as the susceptibility of V. cholerae to
the antimicrobial activity of P3 was generally increased in the presence of fatty acids. On the other
hand, exogenous fatty acid availability did not impact the susceptibility of V. cholerae to P3Cu in
any case excluding the samples grown with 20:4. In the sample grown with 20:4, the MIC had a
2-fold increase.
P1, whose mechanism of action is destabilizing the membrane, inhibits V. cholerae at a
lower MIC than the other isoform when P1 is both metalated and nonmetalated in the absence of
environmental PUFAs. The difference in MIC between P1 and P1Cu versus P3 and P3Cu in the
control samples is significant. In the case of P3, the MIC is increased 4-fold as compared to P1
and P1Cu. The MIC of P3Cu is increased 2-fold compared to the MIC of P1 and P1Cu. P3, whose
mechanism of action is condensing DNA, seems to have a greater impact on V. cholerae when
metalated than it does in the nonmetalated form in the no fatty acid control. The MIC of
nonmetalated P3 is 64 while P3Cu is 32, a 2-fold decrease.
In a study of closely related Vibrio species, the MIC of each species (V. cholerae, V.
parahaemolyticus, and V. vulnificus) was for polymyxin B treated bacteria that was grown with
and without exogenous fatty acid availability [20]. In the case of V. parahaemolyticus, availability
of 20:4 and 18:3-alpha resulted in an increased susceptibility of the bacteria to the antimicrobial
peptide polymyxin B, allowing the subinhibitory concentration to decrease 2-fold [20]. The assays
with V. vulnificus, on the other hand, showed that 20:3, 20:4 and 22:6 actually provided resistance
to polymyxin B, with 22:6 having the most impact and causing a 6-fold decrease in MIC [20].
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Degree of unsaturation seems to impact effectiveness of piscidin activity. 18:2 availability
only had impact on the MIC of one piscidin (P3). This suggests that the metalation could have
some repulsive interaction with 18:2. Similarly, 22:6 only impacted the MIC of P1 and P1Cu,
suggesting that this PUFA is more effective at strengthening the membrane or that V. cholerae has
a greater ability to modify this fatty acid. On the other hand, 20:4 had at least some impact on all
of the piscidins (P1, P1Cu, P3, and P3Cu). This makes since previous research has highlighted the
profound impact that the incorporation of 20:4 has on both membranes and membrane proteins.
These differences beg the question of why and how the degrees of unsaturation could have such
an impact on piscidin activity. Bacteria have the capacity to modify fatty acids through enzymatic
pathways when forming membrane phospholipids [36]. These modifications include elongation,
condensation, forming new double bonds, and changing conformation [36]. It is possible that
varying degrees of unsaturation allow for less energy investment from the bacteria when making
modifications, thus allowing for complete phospholipid biosynthesis tailored to the bacteria’s
environmental composition. The tested hypothesis was not supported entirely, but the permeability
assays with P1 and P3 offer some support, as do the MIC assays with all piscidins excluding P3.
The permeability assays indicate a reduced ability of the non-metalated piscidins to disrupt the
bacterial membrane when 18:2 is available, indicating that this fatty acid incorporation could
provide resistance to these particular piscidins. The MIC assays with P1, P1Cu, and P3Cu all
indicate that the incorporation of fatty acids provide the bacteria some resistance to piscidin as the
concentration of piscidin required to inhibit the growth of the bacteria increased in at least some
of the fatty acid trials.
Regardless of the killing action of each piscidin, penetration of the membrane in some way
is a requirement. The idea that fatty acid availability in a given environment could allow bacteria
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to alter their membrane composition is important, especially for bacteria that oscillate between
aquatic and human reservoirs, each containing their own repertoire of fatty acids. The mechanism
of conferring increased piscidin resistance is intriguing. The possible mechanisms affecting
piscidin membrane passage include steric interference within the bacterial membrane and between
the incorporated fatty acids and the piscidins. Additionally, the impacts that fatty acid assimilation
might have on the electrostatic interactions between the piscidins and the bacterial membrane has
the potential to allow for targeted treatment of infections without many of the issues that
accompany antibiotic treatment. An intriguing prospect from these studies involves the idea that
fatty acid application to sites of infection may introduce bacterial membrane vulnerabilities that
can enhance therapeutic effectiveness.

Future Directions
Since there is still so much debate about the mechanisms of action of each piscidin,
fluorescence and electron microscopy could be utilized to explain discrepancies in behavior
between P1 and P3 both metalated and nonmetalated including but not limited to cell entry in
normal conditions and cell entry under simulated biologically relevant conditions. Repetition of
this study with other PUFAs may hold importance as determinations of biological markers in the
form of fatty acids is possible. This is somewhat seen in the permeability assay with P3, as 18:2
increased V. cholerae’s susceptibility to the antimicrobial activity of P3. Research with other
biologically relevant Gram-negative bacteria compared to Gram-positive bacteria would prove
beneficial to determine how the piscidins interact with peptidoglycan, capsules, lipid bilayers, and
other cellular components that the peptides might encounter. It may be beneficial to study other
fish pathogens and water borne bacteria of medical importance to determine if piscidins may be
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pathogen specific similarly to different drug classes of antibiotics that are utilized in the treatment
of different infections. Research with viral strains should be considered as antimicrobial peptides
might serve to treat viral infections as well as bacterial infections [28]. Further DNA extraction
studies using bacteria treated with P3 could provide invaluable information about the sites that the
piscidin target sites as well as the importance of DNA modification via methylation or
condensation. This could lead into studies that aim to determine if genome length has any impact
on the rate at which P3 inhibits bacterium. In summary, there are several potential avenues for
continued study of piscidin mechanisms and antimicrobial activity. The current study contributed
valuable data concerning piscidin effects on bacterial membrane permeability and antibacterial
efficacy, while supporting further investigation into the roles of piscidins and environmental fatty
acids on pathogenic bacteria.
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